Back to News
Market Impact: 0.35
TEM Q3 Earnings Call Highlights Growth and 2027 Pricing Upside
Source: zacks.com
Artificial IntelligenceHealthcare & BiotechCorporate Guidance & OutlookCompany Fundamentals
Tempus AI raised its 2026 revenue outlook, citing oncology demand, expanding data partnerships and reimbursement-driven pricing gains. The company also pointed to growth prospects for 2027; the article provides no revised revenue figures or market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.45
Ticker Sentiment
TEM0.65
More News
- BTIG raises Tempus AI stock price target to $100 on data deals
- Jefferies upgrades Tempus AI stock rating to hold, raises price target to $70
- Binance co-CEO Richard Teng says hackers used fake job interviews, AI tool to steal $6.3 billion in crypto 108511116
- AMD stock jumps 7% on earnings as data center revenue nearly doubles
- Marvell-Lumentum Deal Puts Optical Networking at the Center of the AI Boom
- Marvell Technology could plunge on latest multibillion-dollar acquisition